Cocrystal Pharma (COCP)

• Market cap: $20.8M
• 1 day: 48.04%
• 5 days: 46.6%
• 1 month: 43.81%
• 3 months: 52.1%
• 6 months: 23.77%
• Year to date: 52.1%
• 1 year: 5.59%
• 5 years: -91.14%
• 10 years: -97.35%
• Sector: Healthcare
• Industry: Biotechnology

About: Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Employees: 11